L E Stevens
Overview
Explore the profile of L E Stevens including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
76
Citations
312
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Missel P, Stevens L
Pharm Dev Technol
. 2006 Mar;
11(1):87-91.
PMID: 16544912
Measurement of drug release of a sparingly soluble drug by conventional methods proceeds very slowly without the aid of surfactants. Two preliminary automated methods were developed that increase sensitivity and...
2.
Missel P, Stevens L, Mauger J
Pharm Dev Technol
. 2004 Dec;
9(4):453-9.
PMID: 15581081
Steady-state drug release rates were measured from a model cylindrical implant, comprised mainly of the sparingly soluble drug anecortave acetate, suspended as an obstacle in a cylindrical flow cell. Dissolution...
3.
Stevens L, de Moore G, Simpson J
Aust N Z J Psychiatry
. 1999 Mar;
32(6):805-8.
PMID: 10084344
Objective: To determine the effect of delirium, as a comorbid diagnosis in hospitalised patients, on patient length of stay (LOS). Method: Prospective study comparing LOS of delirious patients with controls...
4.
Riley D, Classen D, Stevens L, Burke J
Am J Med
. 1995 Apr;
98(4):349-56.
PMID: 7709947
Purpose: The antibacterial activity of silver-containing compounds has recently been employed in constructing medical devices, such as vascular and urinary catheters, that may be effective in blocking infection. The present...
5.
Huff S, Haug P, Stevens L, Dupont R, Pryor T
Proc Annu Symp Comput Appl Med Care
. 1994 Jan;
:271-5.
PMID: 7949933
A new client-server based system which is centered around a lifetime data repository (LDR) is under construction. The goal of the new system is to maintain the patient centered decision...
6.
Pestotnik S, Classen D, Evans R, Stevens L, Burke J
Ann Pharmacother
. 1993 Apr;
27(4):497-501.
PMID: 8477128
Objective: To develop computerized methods to monitor and recommend dosage changes for patients treated with excessive dosages of imipenem/cilastatin (I/C) and to determine the incidence of I/C-associated seizures in our...
7.
Evans R, Classen D, Stevens L, Pestotnik S, Gardner R, Lloyd J, et al.
Proc Annu Symp Comput Appl Med Care
. 1993 Jan;
:161-5.
PMID: 8130454
The most common adverse events experienced by hospitalized patients are drug related. While numerous studies have described the incidence and types of adverse drug events (ADEs), the actual effect of...
8.
Villarino M, Stevens L, Schable B, Mayers G, Miller J, Burke J, et al.
Infect Control Hosp Epidemiol
. 1992 Apr;
13(4):201-6.
PMID: 1593100
Objective: To determine risk factors for and modes of transmission of Xanthomonas maltophilia infection/colonization. Design: Surveillance and cohort study. Setting: A 470-bed tertiary trauma-referral community hospital. Patients: From January 1,...
9.
Huth T, Burke J, Larsen R, Classen D, Stevens L
Arch Intern Med
. 1992 Apr;
152(4):807-12.
PMID: 1558439
Background: Preconnected catheter systems with sealed junctions have been associated with reduced rates of bacteriuria and mortality. A clinical trial was undertaken to evaluate the effectiveness of a junction seal...
10.
Stevens L, Missel P, Lang J
Anal Chem
. 1992 Apr;
64(7):715-23.
PMID: 1524221
An experimental method is described for measuring time-release profiles of drugs from various ophthalmic dosage forms. This in vitro method is carried out under conditions nearly representative of those observed...